Annex II
United Kingdom
Rejected health claims
| Application — Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
|---|---|---|---|
| Article 14(1)(a) health claim referring to a reduction of a disease risk | OPC Premium™ | OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease | Q-2009-00454 |
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Uroval® | Cranberry extract and D-mannose, the main active ingredients of the food supplement Uroval®, eliminate the adhesion of harmful bacteria to the bladder wall. The adhesion of harmful bacteria to the bladder wall is the main risk factor in the development of urinary tract infections | Q-2009-00600 |
| Article 14(1)(b) health claim referring to children’s development and health | Combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) | Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine | Q-2009-00224 |